Ebina, Japan

Keiichi Murayama

This inventor holds 1 USPTO granted patent. Top assignee: Tosoh Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiichi Murayama. Retrieved from https://idiyas.com/inventor/keiichi-murayama-5dx3p2az

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiichi Murayama: Innovator in Cancer Diagnosis

Introduction

Keiichi Murayama is a notable inventor based in Ebina, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of cancers affecting the digestive organs. His innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Murayama holds a patent for "Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain." This patent describes methods for diagnosing cancers of the digestive organs, specifically targeting stomach, colon, and pancreatic cancers through the use of specific antibodies. His work in this area is crucial for advancing cancer detection techniques.

Career Highlights

Keiichi Murayama is associated with Tosoh Corporation, a company known for its advancements in analytical and diagnostic technologies. His role at Tosoh has allowed him to focus on innovative research and development in the medical field. His expertise and dedication have contributed to the company's reputation for excellence in diagnostics.

Collaborations

Murayama has collaborated with esteemed colleagues such as Yong-Suk Chung and Yoshito Yamashita. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Keiichi Murayama's contributions to cancer diagnostics exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…